| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8952035 | Journal of Autoimmunity | 2018 | 7 Pages |
Abstract
A specific antiphospholipid antibody profile could be considered a risk factor associated to CAPS. Early use of a defined treatment protocol based on triple therapy either or not associated with IVIG was associated with recovery in all CAPS patients.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Amelia Ruffatti, Giustina De Silvestro, Piero Marson, Marta Tonello, Antonia Calligaro, Maria Favaro, Teresa Del Ross, Ariela Hoxha, Elena Mattia, Vittorio Pengo,